Leea macrophylla (Roxb.) root extract reverses CCl4 induced liver injury through upregulation of antioxidative gene expression: a molecular interaction for therapeutic inception

다국어 초록 (Multilingual Abstract)

This study investigated the restorative effect of Leea macrophylla ethanol root extract (LMERE) in carbon tetrachloride (CCl4) induced hepatic injury. It also tried to unfold the underlying mechanism through ligand-receptor interactions. Prior to conduct the CCl4 induced animal model study, the in vitro antioxidative capacities of LMERE were investigated. Gas chromatography mass spectroscopy (GC–MS) was accomplished to identify the prevalent bioactive compounds. The molecular docking was performed using Schrödinger Suites 2017-1. Results showed the promising antioxidative potentials of LMERE in in vitro models. Upon treatment of CCl4 intoxicated animals with LMERE, serum ALT and AST were found to be significantly (p < 0.05) reduced compared to the CCl4 control while LMERE50 was noted as the best dose in restoring the hepatic markers. Serum lipids and total protein were significantly restored compared to control. Remarkable changes of cell necrosis, apoptosis and sinusoidal dilution were noticed in histopathological assay of liver tissue. mRNA expression for superoxide dismutase (SOD1) and catalase was multifold increased which are statistically significant compared to reference drug, silymarin. In docking study, octadecanoic acid showed the lowest binding energy and highest binding affinity with the protein (ID: 1VKX) which is a crystallized structure of NF-κB p50/p65 heterodimer involved in cytokine production. The findings demonstrate that LMERE restores the hepatic damage by the mRNA expression of antioxidative enzymes while LMERE50, at a glance, seems the most suitable dose.

참고문헌 (Reference)

1 Nizami AN, "Whole Leea macrophylla ethanolic extract normalizes kidney deposits and recovers renal impairments in an ethylene glycol-induced urolithiasis model of rats" 5 : 533-538, 2012

2 Li S, "The role of oxidative stress and antioxidants in liver diseases" 16 : 26087-26124, 2015

3 Ruot B, "The response of liver albumin synthesis to infection in rats varies with the phase of the inflammatory process" 102 : 107-114, 2002

4 DiMasi JA, "The price of innovation : new estimates of drug development costs" 22 (22): 151-185, 2003

5 Byass P, "The global burden of liver disease : a challenge for methods and for public health" 2014

6 Benzie IFF, "The ferric reducing ability of plasma(FRAP)as a measure of ‘antioxidant power’ : the FRAP assay" 239 : 70-76, 1996

7 Singh J, "Successful shapebased virtual screening : the discovery of a potent inhibitor of the type I TGFβ receptor kinase(TβRI)" 13 (13): 4355-4359, 2003

8 Wang ZJ, "Stearic acid protects primary cultured cortical neurons against oxidative stress" 28 : 315-326, 2007

9 Marí M, "Redox control of liver function in health and disease" 12 : 1295-1331, 2010

10 WHO, "Quality assurance of pharmaceuticals: a compendum of guidelines and related materials, good manufacturing practices and inspection, vol 2" World Health Organization 1996

11 Sastry GM, "Protein and ligand preparation : parameters, protocols, and influence on virtual screening enrichments" 27 (27): 221-234, 2013

12 Olsson MH, "PROPKA3 : consistent treatment of internal and surface residues in empirical pKa predictions" 7 (7): 525-537, 2011

13 Rincón CTS, "Optimizing the extraction of phenolic compounds from Bixa orellana L. and effect of physicochemical conditions on its antioxidant activity" 8 : 1333-1339, 2014

14 Nayal M, "On the nature of cavities on protein surfaces : application to the identification of drug-binding sites" 63 (63): 892-906, 2006

15 Harder E, "OPLS3 : a force field providing broad coverage of drug-like small molecules and proteins" 12 (12): 281-296, 2015

16 Halgren T, "New method for fast and accurate binding-site identification and analysis" 69 (69): 146-148, 2007

17 Roy S, "Medico-botanical report on the Chakma community of Bangladesh" 15 : 67-72, 2008

18 Recknagel RO, "Mechanism of carbon tetrachloride toxicity" 43 : 139-154, 1992

19 Pastor CM, "Liver injury during sepsis" 10 : 183-197, 1995

20 Marcellin P, "Liver diseases : a major, neglected global public health problem requiring urgent actions and large-scale screening" 38 : 2-6, 2018

21 Jahn CE, "Lipoprotein abnormalities in primary biliary cirrhosis association with hepatic lipase inhibition as well as altered cholesterol esterification" 89 : 1266-1278, 1985

22 Ali H, "Isolation and evaluation of anticancer efficacy of stigmasterol in a mouse model of DMBA-induced skin carcinoma" 9 : 2793-2800, 2015

23 Gilmore TD, "Introduction to NF-κB : players, pathways, perspectives" 25 (25): 6680-, 2006

24 Søndergaard CR, "Improved treatment of ligands and coupling effects in empirical calculation and rationalization of pKa values" 7 (7): 2284-2295, 2011

25 Halgren TA, "Identifying and characterizing binding sites and assessing druggability" 49 (49): 377-389, 2009

26 Smirnoff N, "Hydroxyl radical scavenging activity of compatible solutes" 28 : 1057-1060, 1989

27 Saleem TSM, "Hepatoprotective herbs—a review" 1 : 1-5, 2010

28 Sahreen S, "Hepatoprotective effects of methanol extract of Carissa opaca leaves on CCl4-induced damage in rat" 11 : 48-, 2011

29 Girish CK, "Hepatoprotective activity of six polyherbal formulations in paracetamol induced liver toxicity in mice" 129 : 569-578, 2009

30 Halgren TA, "Glide : a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening" 47 (47): 1750-1759, 2004

31 Friesner RA, "Glide : a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy" 47 (47): 1739-1749, 2004

32 Pandey MM, "Free radical scavenging potential of Saussarea costus" 55 : 297-304, 2005

33 Meena AK, "Folk herbal medicines used by the Meena community in Rajasthan" 5 : 19-31, 2010

34 Wu ZY, "Flora of China, vol 12(Hippocastanaceae through Theaceae)" Science Press, Missouri Botanical Garden Press 2007

35 Friesner RA, "Extra precision glide : docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes" 49 (49): 6177-6196, 2006

36 Swarnkar S, "Ethnobotanical observation on tuberous plants from tribal area of Rajasthan(India)" 12 : 647-666, 2008

37 Shelley JC, "Epik : a software program for pK a prediction and protonation state generation for drug-like molecules" 21 : 681-691, 2007

38 Subramoniam A, "Development of phytomedicines for liver diseases" 31 : 166-175, 1999

39 Lin JY, "Determination of total phenolic and flavonoid contents in selected fruits and vegetables, as well as their stimulatory effects on mouse splenocyte proliferation" 101 : 140-147, 2007

40 Parejo I, "Comparison between the radical scavenging activity and antioxidant activity of six distilled and non-distilled Mediterranean herbs and aromatic plants" 50 : 6882-6890, 2002

41 Sanja SD, "Characterization and evaluation of antioxident activity of Portulaca oleracea" 1 : 74-84, 2009

42 Singal AK, "Antioxidants as therapeutic agents for liver disease" 31 : 1432-1448, 2011

43 Genie SA, "Antioxidant and hepatoprotective effects of Crataegus Songarica methanol extract" 33 : 131-143, 2014

44 Dutta S, "Amelioration of CCl4induced liver injury in swiss albino mice by antioxidant rich leaf extract of Croton bonplandianus Baill" 13 (13): e0196411-, 2018

45 Zaoui A, "Acute and chronic toxicity of Nigella sativa fixed oil" 9 : 69-74, 2002

46 Kumar CH, "A review on hepatoprotective activity of medicinal plants" 23 : 501-515, 2011

47 Domitrovic R, "A comprehensive overview of hepatoprotective natural compounds : mechanism of action and clinical perspectives" 90 : 39-79, 2016

48 Thabrew MI, "A comparative study of the efficacy of Pavetta indica and Osbeckia octandra in the treatment of liver dysfunction" 53 : 239-241, 1987